Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Atorvastatin on OPG/RANK/RANKL Expression in Immune Cells and Circulating Levels of Osteoprogenitor Cells

NCT02342015 is registered in ClinicalTrials.gov with University of Padova as lead sponsor.

NCT NCT02342015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02342015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Atorvastatin on OPG/RANK/RANKL Expression in Immune Cells and Circulating Levels of Osteoprogenitor Cells
Lead sponsor
University of Padova
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2012
Completion date
March 31, 2014
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia, osteoporosis